| This week's sponsor is IBM Watson Health. | |  | Visually Explore Real-world Evidence…
...by disease/product, without programming, statistical, or clinical knowledge. Watch our Video
IBM Access and Value Connect: built on MarketScan® claims and Explorys® EHR databases. |
Today's Rundown Featured Story | | | Friday, May 31, 2019 It’s that time of year again, when the big and the small come together to shout about (or try to quietly hide) their latest cancer data at the American Society of Clinical Oncology annual meeting. |
|
|
Top Stories Friday, May 31, 2019 Fosun is pulling back from the U.S. biotech sector in response to the escalating trade war with China. The Chinese conglomerate has struck deals with Kite Pharma, Revance Therapeutics and other U.S. biotechs in the past but now plans to limit its activities in the country. Friday, May 31, 2019 Aslan Pharmaceuticals has secured the global rights to atopic dermatitis candidate ASLAN004 from CLS. The revision of the original deal ties Aslan to milestones including a $30 million payment when ASLAN004 enters phase 3. Thursday, May 30, 2019 In this week's EuroBiotech Report, Gennab files for $500 million IPO, AstraZeneca targets early-stage cancers and Sanofi makes R&D hire. Friday, May 31, 2019 Big Pharma's off-patent medicines face pricing headwinds in China; Pfizer eyes China's rural areas as it moves its Upjohn headquarters to Shanghai; Hansoh Pharma plans to raise as much as $1 billion in a Hong Kong IPO; and more. Friday, May 31, 2019 Novartis' Kymriah head jumps ship to Atara as its R&D chief quits; Gilead's new chief steals BMS executive for top commercial job; and Sanofi hires Atara's Berger to lead development. Those moves plus more hirings, firings and retirings throughout the industry. | This week's sponsor is Medical Sensors Expo & Conference. | |  | |
Resources Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
.jpg/Webp.net-resizeimage%20(2).jpg/20d74ef46d9d96880be5b4c6d56ae9f4)
